
Butantan seeks trials of Brazilian COVID-19 vaccine
The Peninsula
SAO PAULO: Brazil's Butantan biomedical institute will seek approval on Friday to begin human trials for a potential COVID-19 vaccine, officials said, making it the first shot developed in the country to reach clinical testing.
Sao Paulo Governor Joao Doria said the goal was to begin inoculations with the vaccine in July, an aggressive timeline even by the standards of the recent race for new COVID-19 shots. Butantan aims to produce 40 million doses of the new vaccine this year, called Butanvac, starting in May, officials said, aiming to help a sputtering national immunization program, which has done little to stop Brazil's raging coronavirus outbreak.More Related News